31630317|t|Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice.
31630317|a|Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in memory and cognitive impairment. The use of somatostatin receptor subtype-4 (SSTR4) agonists have been proposed for AD treatment. This study investigated the effects of selective SSTR4 agonist NNC 26-9100 on mRNA expression of key genes associated with AD pathology (microglia mediators of Abeta phagocytosis, amyloid-beta (Abeta)-degrading enzymes, anti-oxidant enzymes and pro-inflammatory cytokines) in 3xTg-AD mice. Mice were administered NNC 26-9100 (0.2 microg, i.c.v.) or vehicle control, with cortical and subcortical brain tissue collected at 6 h and 24 h post-treatment. At 6 h, NNC 26-9100 treatment decreased cortical expression of cluster of differentiation-33 (Cd33) by 25%, while increasing cortical and subcortical macrophage scavenger receptor-1 (Msr1) by 1.8 and 2.0-fold, respectively. The Cd33 downregulation and Msr1 upregulation support a state of microglia associated Abeta phagocytosis. At 24 h, NNC 26-9100 treatment increased the cortical expression of Sstr4 (4.9-fold), Abeta-degrading enzymes neprilysin (9.3-fold) and insulin degrading enzyme (14.8-fold), and the antioxidant catalase (3.6-fold). Similar effects at 24 h were found in subcortical tissue with NNC 26-9100 treatment, but did not reach statistical significance. No changes in pro-inflammatory cytokine expression were found. These data demonstrated NNC 26-9100 facilitates transcriptional changes in brain tissue identified with Abeta phagocytosis and clearance, further supporting SSTR4 as a treatment target for AD.
31630317	0	31	Somatostatin Receptor Subtype-4	Gene	20608
31630317	153	157	Mice	Species	10090
31630317	159	178	Alzheimer's disease	Disease	MESH:D000544
31630317	180	182	AD	Disease	MESH:D000544
31630317	201	227	neurodegenerative disorder	Disease	MESH:D019636
31630317	241	272	memory and cognitive impairment	Disease	MESH:D003072
31630317	285	316	somatostatin receptor subtype-4	Gene	20608
31630317	318	323	SSTR4	Gene	20608
31630317	357	359	AD	Disease	MESH:D000544
31630317	420	425	SSTR4	Gene	20608
31630317	434	445	NNC 26-9100	Chemical	MESH:C115929
31630317	494	496	AD	Disease	MESH:D000544
31630317	531	536	Abeta	Gene	11820
31630317	565	570	Abeta	Gene	11820
31630317	620	632	inflammatory	Disease	MESH:D007249
31630317	655	659	mice	Species	10090
31630317	661	665	Mice	Species	10090
31630317	684	695	NNC 26-9100	Chemical	MESH:C115929
31630317	830	841	NNC 26-9100	Chemical	MESH:C115929
31630317	972	1003	macrophage scavenger receptor-1	Gene	20288
31630317	1005	1009	Msr1	Gene	20288
31630317	1074	1078	Msr1	Gene	20288
31630317	1132	1137	Abeta	Gene	11820
31630317	1161	1172	NNC 26-9100	Chemical	MESH:C115929
31630317	1220	1225	Sstr4	Gene	20608
31630317	1238	1243	Abeta	Gene	11820
31630317	1262	1272	neprilysin	Gene	17380
31630317	1288	1312	insulin degrading enzyme	Gene	15925
31630317	1346	1354	catalase	Gene	12359
31630317	1429	1440	NNC 26-9100	Chemical	MESH:C115929
31630317	1514	1526	inflammatory	Disease	MESH:D007249
31630317	1583	1594	NNC 26-9100	Chemical	MESH:C115929
31630317	1663	1668	Abeta	Gene	11820
31630317	1716	1721	SSTR4	Gene	20608
31630317	1748	1750	AD	Disease	MESH:D000544
31630317	Positive_Correlation	MESH:C115929	20288
31630317	Positive_Correlation	MESH:C115929	20608
31630317	Association	11820	15925
31630317	Positive_Correlation	MESH:C115929	17380
31630317	Association	MESH:D000544	11820
31630317	Association	MESH:C115929	11820
31630317	Association	11820	20288
31630317	Positive_Correlation	MESH:C115929	15925
31630317	Association	MESH:D000544	20608
31630317	Association	11820	17380
31630317	Positive_Correlation	MESH:C115929	12359

